CYP3A4 mutation causes vitamin D-dependent rickets type 3

被引:77
作者
Roizen, Jeffrey D. [1 ]
Li, Dong [2 ]
O'Lear, Lauren [1 ]
Javaid, Muhammad K. [3 ]
Shaw, Nicholas J. [4 ,5 ]
Ebeling, Peter R. [6 ]
Nguyen, Hanh H. [6 ]
Rodda, Christine P. [7 ,8 ]
Thummel, Kenneth E. [9 ]
Thacher, Tom D. [10 ]
Hakonarson, Hakon [2 ]
Levine, Michael A. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia CHOP, Ctr Appl Genom, Philadelphia, PA 19104 USA
[3] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[4] Univ Birmingham, Birmingham Childrens Hosp, Dept Endocrinol & Diabet, Birmingham, W Midlands, England
[5] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England
[6] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic, Australia
[7] Univ Melbourne, Australian Inst Musculoskeletal Sci, Sunshine Hosp, Parkville, Vic, Australia
[8] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia
[9] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
[10] Mayo Clin, Dept Family Med, Rochester, MN USA
关键词
25-HYDROXYVITAMIN D-3; INDUCTION; METABOLISM; PATHWAY; GENE; 1,25-DIHYDROXYVITAMIN-D3; GENOTYPE; SEX;
D O I
10.1172/JCI98680
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Genetic forms of vitamin D-dependent rickets (VDDRs) are due to mutations impairing activation of vitamin D or decreasing vitamin D receptor responsiveness. Here we describe two unrelated patients with early-onset rickets, reduced serum levels of the vitamin D metabolites 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and deficient responsiveness to parent and activated forms of vitamin D. Neither patient had a mutation in any genes known to cause VDDR; however, using whole exome sequencing analysis, we identified a recurrent de novo missense mutation, c.902T>C (p. I301T), in CYP3A4 in both subjects that alters the conformation of substrate recognition site 4 (SRS-4). In vitro, the mutant CYP3A4 oxidized 1,25-dihydroxyvitamin D with 10-fold greater activity than WT CYP3A4 and 2-fold greater activity than CYP24A1, the principal inactivator of vitamin D metabolites. As CYP3A4 mutations have not previously been linked to rickets, these findings provide insight into vitamin D metabolism and demonstrate that accelerated inactivation of vitamin D metabolites represents a mechanism for vitamin D deficiency.
引用
收藏
页码:1913 / 1918
页数:6
相关论文
共 23 条
[1]   Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance [J].
Chen, H ;
Hewison, M ;
Hu, B ;
Adams, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6109-6114
[2]   Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase [J].
Cheng, JB ;
Levine, MA ;
Bell, NH ;
Mangelsdorf, DJ ;
Russell, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (20) :7711-7715
[3]   4β-Hydroxycholesterol is a new endogenous CYP3A marker:: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians [J].
Diczfalusy, Ulf ;
Miura, Jun ;
Roh, Hyung-Keun ;
Mirghani, Rajaa A. ;
Sayi, Jane ;
Larsson, Hanna ;
Bodin, Karl G. ;
Allqvist, Annika ;
Jande, Mary ;
Kim, Jong-Wook ;
Aklillu, Eleni ;
Gustafsson, Lars L. ;
Bertilsson, Leif .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (03) :201-208
[4]   Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin [J].
Dutreix, Catherine ;
Lorenzo, Sebastien ;
Wang, Yanfeng .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (08) :915-920
[5]   CYP3A4 is a vitamin D-24- and 25-hydroxylase: Analysis of structure function by site-directed mutagenesis [J].
Gupta, RP ;
He, YA ;
Patrick, KS ;
Halpert, JR ;
Bell, NH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :1210-1219
[6]   CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations [J].
Hawkes, Colin Patrick ;
Li, Dong ;
Hakonarson, Hakon ;
Meyers, Kevin E. ;
Thummel, Kenneth E. ;
Levine, Michael A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (05) :1440-1446
[7]   The CYP3A4*18 Genotype in the Cytochrome P450 3A4 Gene, a Rapid Metabolizer of Sex Steroids, Is Associated With Low Bone Mineral Density [J].
Kang, Y. S. ;
Park, S. Y. ;
Yim, C. H. ;
Kwak, H. S. ;
Gajendrarao, P. ;
Krishnamoorthy, N. ;
Yun, S-C ;
Lee, K. W. ;
Han, K. O. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) :312-318
[8]   Structure-function analysis of human cytochrome P450 3A4 using 7-alkoxycoumarins as active-site probes [J].
Khan, KK ;
Halpert, JR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 373 (02) :335-345
[9]   Inactivating mutations in the 25-hydroxyvitamin D3 1α-hydroxylase gene in patients with pseudovitamin D-deficiency rickets [J].
Kitanaka, S ;
Takeyama, K ;
Murayama, A ;
Sato, T ;
Okumura, K ;
Nogami, M ;
Hasegawa, Y ;
Niimi, H ;
Yanagisawa, J ;
Tanaka, T ;
Kato, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :653-661
[10]   Comparative analysis of human CYP3A4 and rat CYP3A1 induction and relevant gene expression by bisphenol A and diethylstilbestrol: Implications for toxicity testing paradigms [J].
Kuzbari, Oumar ;
Peterson, C. Matthew ;
Franklin, Michael R. ;
Hathaway, Laura B. ;
Johnstone, Erica B. ;
Hammoud, Ahmad O. ;
Lamb, John G. .
REPRODUCTIVE TOXICOLOGY, 2013, 37 :24-30